Freeman Mason - Insider Non-Derivative Transactions at CinCor Pharma, Inc. (CINC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 24, 2023, Freeman Mason's relationship to CinCor Pharma, Inc. (CINC) is Officer (Chief Medical Officer), and currently has 40,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CINC insiders.
Data Source: SEC.
Freeman Mason - Insider Non-Derivative Transactions of CINC Common Stock
Freeman Mason - Insider Non-Derivative Transactions at CINC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 25, 2023 | Disposition -- (Common Stock) | 40000 | 0 | 0 |
| Feb 25, 2023 | U -- (Common Stock) | 100 | 0 | 0 |
| Feb 25, 2023 | U -- (Common Stock) | 2494 | 0 | 40000 |
| Jan 27, 2023 | Acquisition -- (Common Stock) | 40000 | 0 | 42500 |
| Jun 11, 2022 | Sell -- (Common Stock) | 6 | 15.21 | 2494 |